{"id":"W3203575639","doi":"10.1016/j.annonc.2021.08.1053","title":"531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Jewish General Hospital","funders":"Servier; Pfizer; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007246113,0.000792544,0.00091373,0.0001693155,0.0002015828,0.0008389502,0.0002968713,0.0005369329,0.003261043],"category_scores_gemma":[0.0005927368,0.0001684072,0.0006874334,0.0002327288,0.0003246942,0.0006153833,0.0002871649,0.002055302,0.0006447008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007095568,"about_ca_system_score_gemma":0.0006498233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001027426,"about_ca_topic_score_gemma":0.006377933,"domain_scores_codex":[0.9998451,0.00005771288,0.000005521202,0.00002122063,0.0000210092,0.0000494008],"domain_scores_gemma":[0.9997397,0.00005762326,0.00004484986,0.00001513639,0.000017021,0.0001257151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4754609,0.009637076,0.01020268,0.00147589,0.00222983,0.0006363891,0.0002023685,0.005869155,0.03415538,0.001899991,0.02672331,0.4315071],"study_design_scores_gemma":[0.7211111,0.1533805,0.05958971,0.000266472,0.001753877,0.001808557,0.0001981858,0.005928736,0.007632793,0.003559147,0.04466826,0.0001025541],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793032,0.006220147,0.0006383483,0.001989877,0.000229672,0.0005343689,0.002283797,0.0001454059,0.008655158],"genre_scores_gemma":[0.9767261,0.005188334,0.001621105,0.001896688,0.000149282,0.0006509528,0.004174249,0.00003939478,0.009553889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003261043,"threshold_uncertainty_score":0.01090926,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0708436817400616,"score_gpt":0.3694569890258601,"score_spread":0.2986133072857985,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}